Silver bullet
Nanoparticles of the metal can prevent blood clots
blood clots are a common cause of heart attacks, strokes and coronary arterial diseases. Clots block arteries, choke blood and oxygen supply to tissues, thus killing them. The way to deal with this is to take anticoagulants, like aspirin and heparin, which thin the blood. But in large doses they can cause excessive bleeding. However, sedentary lifestyle and high incidences of these diseases have increased the use of such drugs.
Siddhartha Shrivastava and his colleagues at the department of biochemistry, Banaras Hindu University, Varanasi, have found an alternative to these drugs. They have used ultra fine silver particles called nanoparticles to inhibit platelets, cells that aggregate to form clots. Nanoparticles can have a diameter as small as a billionth of a metre.
Usually, nanoparticles are used to deliver medicines, in the proper doses, to specific tissues. But silver nanoparticles have the innate property of inhibiting platelets. Shrivastava
Related Content
- Carbon pricing for climate action
- Clearing the air: a tale of three cities
- Earlier phase-out of fossil-fuel cars in the UK welcomed
- Mission possible: how carmakers can reach their 2021 CO2 targets and avoid fines
- Putting a price on carbon: evaluating a carbon price and complementary policies for a 1.5° world
- Creating a sustainable food future: a menu of solutions to feed nearly 10 billion people by 2050